Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Air France, Edenred, GlaxoSmithKline: European Equity Preview

The following companies’ shares may have unusual moves in European trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index lost 1 percent to 236.22. The Stoxx 50 Index slipped 0.6 percent to 2,257.58. The Euro Stoxx 50 Index, a benchmark measure for nations using the euro, fell 1.7 percent to 2,315.89.

Air France-KLM (AF FP): Europe’s largest airline ousted Pierre-Henri Gourgeon as chief executive officer and appointed Chaiman Jean-Cyril Spinetta to take charge as it struggles with slumping earnings and revelations regarding the role of pilots in a fatal crash. The shares gained 1.4 percent to 5.61 euros.

Air Liquide SA (AI FP): The industrial gas producer won a contract from South Korean steelmaker Posco to build two air separation units. The contract is Air Liquide’s biggest for a steelmaker in terms of production capacity. The shares lost 0.9 percent to 91.61 euros.

Edenred (EDEN FP): The seller of meal and service vouchers reported third-quarter revenue rose to 245 million euros ($336 million) from 226 million euros a year earlier, led by a gain in Latin America. Shares dropped 3 percent to 18.57 euros.

GlaxoSmithKline Plc (GSK LN): The U.K.’s largest drugmaker may face competition in the sale of its antiviral drug Selzentry, used in the treatment of human immunodeficiency virus. An unidentified generic company filed an application to sell copies of the drug before patents expire in 2021, the U.S. Food and Drug Administration said. Glaxo reported $123.7 million in sales of Selzentry in 2010.

Mercialys (MERY FP): The real-estate investment trust controlled by retailer Casino Guichard-Perrachon SA said nine-month rental revenue rose 8.3 percent to 109.93 million euros. Shares lost 0.1 percent to 27.50 euros.

Soitec (SOI FP): The supplier of silicon wafers’ first-half revenue rose 18 percent to 162.6 million euros. Shares jumped 3.8 percent to 4.59 euros.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.